Issue 16, 2024

Recent advances in therapeutic engineered extracellular vesicles

Abstract

Extracellular vesicles (EVs) are natural particles secreted by living cells, which hold significant potential for various therapeutic applications. Native EVs have specific components and structures, allowing them to cross biological barriers, and circulate in vivo for a long time. Native EVs have also been bioengineered to enhance their therapeutic efficacy and targeting affinity. Recently, the therapeutic potential of surface-engineered EVs has been explored in the treatment of tumors, autoimmune diseases, infections and other diseases by ongoing research and clinical trials. In this review, we will introduce the modified methods of engineered EVs, summarize the application of engineered EVs in preclinical and clinical trials, and discuss the opportunities and challenges for the clinical translation of surface-engineered EVs.

Graphical abstract: Recent advances in therapeutic engineered extracellular vesicles

Article information

Article type
Minireview
Submitted
30 okt 2023
Accepted
04 mar 2024
First published
27 mar 2024

Nanoscale, 2024,16, 7825-7840

Recent advances in therapeutic engineered extracellular vesicles

C. Yao, H. Zhang and C. Wang, Nanoscale, 2024, 16, 7825 DOI: 10.1039/D3NR05470E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements